Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000271

Director sold 16,000 shares at $75.10 ($1,201,669)

  • Director acquired 16,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LOSCALZO JOSEPH · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-31 Exercise or conversion : show line 1 in the form 10b5-1 +16,000 $52.22 $835,520 52,330 D
2025-10-31 Sale : show line 2 in the form 10b5-1 −16,000 $75.10 $1,201,669 36,330 D
Open-market sales · 16,000 sh · avg $75.10 · $1,201,669

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-31 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −16,000 0 D
Loading xslF345X05/edgardoc.xml…